Reference
Aznar ML, et al. Safety and effectiveness of low-dose amikacin in nontuberculous mycobacterial pulmonary disease treated in Toronto, Canada. BMC Pharmacology & Toxicology 20: 37, No. 1, 3 Jun 2019. Available from: URL: http://doi.org/10.1186/s40360-019-0302-1 - Canada
Rights and permissions
About this article
Cite this article
Amikacin. Reactions Weekly 1762, 29 (2019). https://doi.org/10.1007/s40278-019-64768-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-64768-x